Annual FCF:
-$98.88M+$68.14M(+40.80%)Summary
- As of today (October 3, 2025), ADPT annual free cash flow is -$98.88 million, with the most recent change of +$68.14 million (+40.80%) on December 31, 2024.
- During the last 3 years, ADPT annual free cash flow has risen by +$155.60 million (+61.14%).
- ADPT annual free cash flow is now -150.91% below its all-time high of $194.20 million, reached on December 31, 2019.
Performance
ADPT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$13.09M+$16.66M(+56.01%)Summary
- As of today (October 3, 2025), ADPT quarterly free cash flow is -$13.09 million, with the most recent change of +$16.66 million (+56.01%) on June 30, 2025.
- Over the past year, ADPT quarterly free cash flow has increased by +$5.95 million (+31.25%).
- ADPT quarterly free cash flow is now -104.77% below its all-time high of $274.47 million, reached on March 31, 2019.
Performance
ADPT Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$82.81M+$5.95M(+6.70%)Summary
- As of today (October 3, 2025), ADPT TTM free cash flow is -$82.81 million, with the most recent change of +$5.95 million (+6.70%) on June 30, 2025.
- Over the past year, ADPT TTM free cash flow has increased by +$53.78 million (+39.37%).
- ADPT TTM free cash flow is now -131.06% below its all-time high of $266.57 million, reached on March 31, 2019.
Performance
ADPT TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ADPT Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +40.8% | +31.3% | +39.4% |
3Y3 Years | +61.1% | +75.0% | +65.6% |
5Y5 Years | -150.9% | +60.8% | +44.2% |
ADPT Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +61.1% | -4.1% | +78.9% | at high | +64.1% |
5Y | 5-Year | -150.9% | +61.1% | -4.1% | +82.3% | at high | +67.5% |
All-Time | All-Time | -150.9% | +61.1% | -104.8% | +82.3% | -131.1% | +67.5% |
ADPT Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$13.09M(-56.0%) | -$82.81M(-6.7%) |
Mar 2025 | - | -$29.74M(+136.6%) | -$88.75M(-10.2%) |
Dec 2024 | -$98.88M(-40.8%) | -$12.57M(-54.1%) | -$98.88M(-13.7%) |
Sep 2024 | - | -$27.41M(+44.0%) | -$114.53M(-16.1%) |
Jun 2024 | - | -$19.03M(-52.3%) | -$136.59M(-5.7%) |
Mar 2024 | - | -$39.86M(+41.2%) | -$144.81M(-13.3%) |
Dec 2023 | -$167.02M(-16.6%) | -$28.23M(-42.9%) | -$167.02M(-2.5%) |
Sep 2023 | - | -$49.46M(+81.5%) | -$171.35M(+1.0%) |
Jun 2023 | - | -$27.25M(-56.1%) | -$169.73M(-12.9%) |
Mar 2023 | - | -$62.08M(+90.6%) | -$194.84M(-2.7%) |
Dec 2022 | -$200.29M(-21.3%) | -$32.56M(-31.9%) | -$200.29M(-13.2%) |
Sep 2022 | - | -$47.84M(-8.6%) | -$230.80M(-4.2%) |
Jun 2022 | - | -$52.36M(-22.5%) | -$241.03M(-2.8%) |
Mar 2022 | - | -$67.53M(+7.1%) | -$247.92M(-2.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$254.47M(+51.0%) | -$63.07M(+8.6%) | -$254.47M(+5.8%) |
Sep 2021 | - | -$58.06M(-2.0%) | -$240.62M(+2.9%) |
Jun 2021 | - | -$59.25M(-20.0%) | -$233.92M(+12.5%) |
Mar 2021 | - | -$74.09M(+50.5%) | -$208.00M(+23.5%) |
Dec 2020 | -$168.49M(-186.8%) | -$49.21M(-4.2%) | -$168.49M(+13.5%) |
Sep 2020 | - | -$51.36M(+54.1%) | -$148.48M(+13.6%) |
Jun 2020 | - | -$33.34M(-3.6%) | -$130.68M(+13.8%) |
Mar 2020 | - | -$34.57M(+18.4%) | -$114.84M(-159.1%) |
Dec 2019 | $194.20M(-603.7%) | -$29.21M(-13.0%) | $194.20M(-9.9%) |
Sep 2019 | - | -$33.57M(+91.9%) | $215.51M(-13.5%) |
Jun 2019 | - | -$17.49M(-106.4%) | $249.07M(-6.6%) |
Mar 2019 | - | $274.47M(-3572.1%) | $266.57M(-1926.3%) |
Dec 2018 | -$38.56M(+3.2%) | -$7.91M(+18.1%) | -$14.60M(+118.1%) |
Mar 2018 | - | -$6.69M | -$6.69M |
Dec 2017 | -$37.36M | - | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual free cash flow?
- What is the all-time high annual free cash flow for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual free cash flow year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly free cash flow year-on-year change?
- What is Adaptive Biotechnologies Corporation TTM free cash flow?
- What is the all-time high TTM free cash flow for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation TTM free cash flow year-on-year change?
What is Adaptive Biotechnologies Corporation annual free cash flow?
The current annual free cash flow of ADPT is -$98.88M
What is the all-time high annual free cash flow for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual free cash flow is $194.20M
What is Adaptive Biotechnologies Corporation annual free cash flow year-on-year change?
Over the past year, ADPT annual free cash flow has changed by +$68.14M (+40.80%)
What is Adaptive Biotechnologies Corporation quarterly free cash flow?
The current quarterly free cash flow of ADPT is -$13.09M
What is the all-time high quarterly free cash flow for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly free cash flow is $274.47M
What is Adaptive Biotechnologies Corporation quarterly free cash flow year-on-year change?
Over the past year, ADPT quarterly free cash flow has changed by +$5.95M (+31.25%)
What is Adaptive Biotechnologies Corporation TTM free cash flow?
The current TTM free cash flow of ADPT is -$82.81M
What is the all-time high TTM free cash flow for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high TTM free cash flow is $266.57M
What is Adaptive Biotechnologies Corporation TTM free cash flow year-on-year change?
Over the past year, ADPT TTM free cash flow has changed by +$53.78M (+39.37%)